Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Fuller

Showing results (181-190 of 199) with videos related to

Pageof 20
Sort By:
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 26, 2016
Intensity-modulated proton beam therapy (IMPT) versus intensity-modulated photon therapy (IMRT) for patients with oropharynx cancer - A case matched analysisPierre Blanchard, Adam S Garden, G Brandon Gunn, et al.
European Journal of Cancer (Oxford, England : 1990)|July 24, 2020
Progression-free survival is a suboptimal predictor for overall survival among metastatic solid tumour clinical trialsDario Pasalic, Gwendolyn J McGinnis, C David Fuller, et al.
Journal of the National Cancer Institute|July 28, 2019
Sex-Based Disparities Among Cancer Clinical Trial ParticipantsEthan B Ludmir, C David Fuller, Shalini Moningi, et al.
Journal of Geriatric Oncology|November 13, 2019
Decreasing incidence of upper age restriction enrollment criteria among cancer clinical trialsEthan B Ludmir, Ishwaria M Subbiah, Walker Mainwaring, et al.
Thyroid : Official Journal of the American Thyroid Association|July 20, 2019
Complete Surgical Resection Following Neoadjuvant Dabrafenib Plus Trametinib in <i>BRAF</i>-Mutated Anaplastic Thyroid CarcinomaJennifer R Wang, Mark E Zafereo, Ramona Dadu, et al.
Medrxiv : the Preprint Server for Health Sciences|September 25, 2023
Development and Standardization of a Classification System for Osteoradionecrosis: Implementation of a Risk-Based ModelErin E Watson, Katrina Hueniken, Junhyung Lee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 2024
Prevention and Management of Osteoradionecrosis in Patients With Head and Neck Cancer Treated With Radiation Therapy: ISOO-MASCC-ASCO GuidelineDouglas E Peterson, Shlomo A Koyfman, Noam Yarom, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|October 6, 2020
Performance Status Restriction in Phase III Cancer Clinical TrialsJoseph Abi Jaoude, Ramez Kouzy, Walker Mainwaring, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 3, 2024
Patterns of loco-regional progression and patient outcomes after definitive-dose radiation therapy for anaplastic thyroid cancerJulianna K Bronk, Alexander Augustyn, Abdallah S R Mohamed, et al.
Practical Radiation Oncology|March 17, 2016
The role of elective nodal irradiation for esthesioneuroblastoma patients with clinically negative neckWen Jiang, Abdallah S R Mohamed, Clifton David Fuller, et al.
Pageof 20

Showing results (181-190 of 199) with videos related to

Sort By:
Pageof 20
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 26, 2016
Intensity-modulated proton beam therapy (IMPT) versus intensity-modulated photon therapy (IMRT) for patients with oropharynx cancer - A case matched analysisPierre Blanchard, Adam S Garden, G Brandon Gunn, et al.
European Journal of Cancer (Oxford, England : 1990)|July 24, 2020
Progression-free survival is a suboptimal predictor for overall survival among metastatic solid tumour clinical trialsDario Pasalic, Gwendolyn J McGinnis, C David Fuller, et al.
Journal of the National Cancer Institute|July 28, 2019
Sex-Based Disparities Among Cancer Clinical Trial ParticipantsEthan B Ludmir, C David Fuller, Shalini Moningi, et al.
Journal of Geriatric Oncology|November 13, 2019
Decreasing incidence of upper age restriction enrollment criteria among cancer clinical trialsEthan B Ludmir, Ishwaria M Subbiah, Walker Mainwaring, et al.
Thyroid : Official Journal of the American Thyroid Association|July 20, 2019
Complete Surgical Resection Following Neoadjuvant Dabrafenib Plus Trametinib in <i>BRAF</i>-Mutated Anaplastic Thyroid CarcinomaJennifer R Wang, Mark E Zafereo, Ramona Dadu, et al.
Medrxiv : the Preprint Server for Health Sciences|September 25, 2023
Development and Standardization of a Classification System for Osteoradionecrosis: Implementation of a Risk-Based ModelErin E Watson, Katrina Hueniken, Junhyung Lee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 2024
Prevention and Management of Osteoradionecrosis in Patients With Head and Neck Cancer Treated With Radiation Therapy: ISOO-MASCC-ASCO GuidelineDouglas E Peterson, Shlomo A Koyfman, Noam Yarom, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|October 6, 2020
Performance Status Restriction in Phase III Cancer Clinical TrialsJoseph Abi Jaoude, Ramez Kouzy, Walker Mainwaring, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 3, 2024
Patterns of loco-regional progression and patient outcomes after definitive-dose radiation therapy for anaplastic thyroid cancerJulianna K Bronk, Alexander Augustyn, Abdallah S R Mohamed, et al.
Practical Radiation Oncology|March 17, 2016
The role of elective nodal irradiation for esthesioneuroblastoma patients with clinically negative neckWen Jiang, Abdallah S R Mohamed, Clifton David Fuller, et al.
Pageof 20